CDK4-6 inhibitors in breast cancer: current status and future development
10.1080/17425255.2018.1541347
Saved in:
Main Authors: | Joan Choo, Soo-Chin Lee |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Published: |
Taylor & Francis
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/149940 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
by: Palafox, Marta, et al.
Published: (2023) -
CDK4/6 INHIBITORS AS NOVEL THERAPY IN NASOPHARYNGEAL CARCINOMA
by: BUI NGOC LINH CHI
Published: (2021) -
Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions
by: Sopee Poomsawat, et al.
Published: (2018) -
Clinical pharmacology in Singapore: Current status and future developments
by: Lee, E.J.D.
Published: (2014) -
Cdk2 and Cdk4 cooperatively control the expression of Cdc2
by: Berthet, C, et al.
Published: (2020)